SCHEMBL16744508

SCHEMBL16744508

Cc1ccc(-c2cc(CN3CCN(C(=O)OC(C)(C)C)CC3)no2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCD5 Q86SK9 2/20 0.52
LMNA P02545 1/20 0.50
MAPK1 P28482 1/20 0.50
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
TSHR P16473 2/20 0.47
TP53 P04637 2/20 0.47
ALDH1A1 P00352 1/20 0.47
HPGD P15428 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MAPT P10636 3/20 0.45
HTT P42858 1/20 0.45
HDAC4 P56524 1/20 0.44
KDM1A O60341 1/20 0.43
TUBB4A P04350 1/20 0.43
TUBB P07437 1/20 0.43
TUBA3C P0DPH7 1/20 0.43
TUBA1B P68363 1/20 0.43
TUBA4A P68366 1/20 0.43
TUBB4B P68371 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15093710 0.90 SCD5 (0.57) SCD5LMNANPC1RAB9AALDH1A1
SCHEMBL15094284 0.89 MAPT (0.52) SCD5LMNAMAPK1NPC1RAB9A
SCHEMBL16744481 0.83 MGLL (0.53) LMNAMAPK1
SCHEMBL207984 0.83 CHRM2 (0.44) SCD5ALDH1A1SMN1; SMN2HDAC4IKBKE
SCHEMBL16577089 0.82 LMNA (0.48) LMNAMAPK1NPC1RAB9ATSHR
SCHEMBL18623641 0.79 ATM (0.46) LMNAMAPK1NPC1RAB9ATSHR
SCHEMBL2858333 0.77 TP53 (0.58) LMNATSHRTP53ALDH1A1SMN1; SMN2
SCHEMBL20160543 0.77 TP53 (0.48) TSHRTP53ALDH1A1SMN1; SMN2MAPT
SCHEMBL5958562 0.76 KMT2A (0.58) LMNAMAPK1TSHRALDH1A1HPGD
SCHEMBL9933243 0.76 CHRM2 (0.46) SCD5MAPK1NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230312499-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2023-10-05 US disclosed
CN-107982266-B Carbamate compounds and methods of making and using the same H.隆德贝克有限公司 2021-07-30 CN disclosed
US-20180208568-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2018-07-26 US disclosed
US-9957242-B2 Carbamate compounds and methods of making and using same THE SCRIPPS RESEARCH INSTITUTE (US) 2018-05-01 US disclosed
US-20170073320-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2017-03-16 US disclosed
US-9487495-B2 Carbamate compounds and of making and using same THE SCRIPTS RESEARCH INSTITUTE (US) 2016-11-08 US disclosed
US-9133148-B2 Carbamate compounds and of making and using same THE SCRIPPS RESEARCH INSTITUTE (US) 2015-09-15 US disclosed
US-20150148330-A1 CARBAMATE COMPOUNDS AND OF MAKING AND USING SAME H. LUNDBECK A/S (DK) 2015-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180208568-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABHD6, ABHD16A, NCEH1 SCD5 680/4885LMNA 4712/4885MAPK1 4566/4885
US-20230312499-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABHD6, ABHD16A, RABL6 SCD5 1767/4885LMNA 4184/4885MAPK1 3735/4885
US-20150148330-A1 CARBAMATE COMPOUNDS AND OF MAKING AND USING SAME ABHD6, ABHD16A, PRMT6 SCD5 640/4885LMNA 4728/4885MAPK1 4434/4885
US-20170073320-A1 CARBAMATE COMPOUNDS AND METHODS OF MAKING AND USING SAME ABHD6, ABHD16A, NCEH1 SCD5 680/4885LMNA 4712/4885MAPK1 4566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.